Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Canon agrees to buy Toshiba's medical equipment unit for 4 billion pounds

Published 17/03/2016, 07:05
Updated 17/03/2016, 07:05
© Reuters. Man walks past a Canon logo in Tokyo

TOKYO (Reuters) - Canon Inc has agreed to buy Toshiba Corp's medical equipment unit for 665.5 billion yen (4 billion pounds), the companies said on Thursday.

Toshiba, which is selling the unit to help fund restructuring after a massive accounting scandal, said the deal would yield a profit of about 590 billion yen in the current fiscal year ending this month if it closes in time.

The Japanese maker of cameras and office equipment last week won exclusive negotiating rights to buy Toshiba Medical Corp in a hotly contested auction.

Canon, which makes X-ray machines and eye examination devices, has been trying for years to expand into high-margin medical devices, particularly as demand for cameras has declined with the advent of smartphones.

Toshiba Chief Executive Masashi Muromachi is trying to overhaul the laptops-to-nuclear conglomerate following last year's revelations of overstated profits going back to around 2009. He has announced more than 10,000 job cuts and also plans to sell its loss-making laptops and home appliances businesses.

Funds from the deal will help enable Toshiba to drop plans to seek about $1.8 billion in additional loans from Sumitomo Mitsui Banking Corp, Mizuho Bank and Sumitomo Mitsui Trust Bank, sources familiar with the situation said on Tuesday.

But in a sign of yet more difficulty for Toshiba to overcome the multi-billion dollar accounting scandal, Bloomberg News reported U.S. authorities were investigating it over accounting related to its Westinghouse nuclear power operations.

The Justice Department and Securities Exchange Commission were looking into the possibility of fraud, the report said. Toshiba shares fell nearly 8 percent on Thursday after the report.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.